Ketamine-assisted psychotherapy / Depression · Phase 1/2 Trial
ClinicalTrials.gov · September 10, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned Phase 1/2 pilot trial of ketamine-assisted group therapy adapted for Spanish-speaking adults with depression in a community setting. The study aims to evaluate feasibility, safety, and preliminary efficacy, but no results have been posted in this registry record. The reader should note this is a very early-stage effort in an under-resourced population and should await outcome data.
Phase 1/2, Interventional, Single Group, Open label, Other purpose. Depression; age from 18 Years; to 64 Years. Intervention: Open label. n = 10. 1 site: United States.
This is a planned Phase 1/2 pilot trial of ketamine-assisted group therapy adapted for Spanish-speaking adults with depression in a community setting. The study aims to evaluate feasibility, safety, and preliminary efficacy, but no results have been posted in this registry record. The reader should note this is a very early-stage effort in an under-resourced population and should await outcome data.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
No clinical impact can be assessed at this stage. Readers should monitor for results publication to determine feasibility and safety signals in this underserved population.
This is an early-phase pilot trial (Phase 1/2) assessing feasibility and safety in a small planned cohort, with no results yet reported in the registry record.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can be assessed at this stage. Readers should monitor for results publication to determine feasibility and safety signals in this underserved population.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06597695). This is a study registration, not published results. Lead sponsor: Juliana Zambrano, MD, MPH. Recruitment status: RECRUITING. Phase: PHASE1, PHASE2. Study type: INTERVENTIONAL. Enrollment: 10 participants (ESTIMATED). Conditions: Depression. Interventions: DRUG: Ketamine-assisted psychotherapy. Primary outcome measures: Evaluate feasibility of a culturally adapted group-based ketamine intervention for Spanish- speaking adults with depression in a community setting , 1 week post-intervention; To assess the safety of a ketamine-assisted group psychotherapy intervention for Spanish-speaking participants with depression in a community setting. , 1 week post-intervention. Brief summary: This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.